Recruiting PHASE2 TBI Traumatic Brain Injury

New treatment option for TBI Traumatic Brain Injury

Official title Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy

ClinicalTrials.gov ID: NCT07214415

What this study is testing

What is Hyperbaric Oxygen Therapy?

Hyperbaric Oxygen Therapy is an investigational medicine, being studied as a potential treatment for tbi traumatic brain injury.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The purpose of this study is to evaluate how hyperbaric oxygen therapy (HBOT) may affect cognitive functioning, post-traumatic stress disorder (PTSD), depression, anxiety, and overall quality of life in veterans. 1.
  • Phase 2: a mid-size study of how well it works

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 75

You may be able to join if

  • At least 18 years of age.
  • Veteran status
  • Clinically diagnosed with a mTBI, PTSD, Anxiety, or Depression disorder by meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth...
  • The subject is willing and able to read, understand, and sign an informed consent. Additionally, the subject has clear consciousness and the ability...
  • Exposed to at least one trauma-focused therapy or evidence-based psychotherapeutic treatment, such as prolonged exposure therapy, EMDR, or CBT, to...

You likely can't join if

  • Untreated pneumothorax
  • History of spontaneous pneumothorax
  • Severe sinus infection
  • Upper respiratory infection
  • Asymptomatic pulmonary lesions on chest x-ray
  • Uncontrollable high fever (greater than 39C)
See the full eligibility criteria
Who can join
  • At least 18 years of age.
  • Veteran status
  • Clinically diagnosed with a mTBI, PTSD, Anxiety, or Depression disorder by meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and by a qualified and trained professional.
  • The subject is willing and able to read, understand, and sign an informed consent. Additionally, the subject has clear consciousness and the ability to express self-feelings independently.
  • Exposed to at least one trauma-focused therapy or evidence-based psychotherapeutic treatment, such as prolonged exposure therapy, EMDR, or CBT, to name a few.
  • Completed cognitive and psychological measurements.
  • Clinical diagnoses cause significant impairment in social or occupational functioning or some other functional capacity.
  • Sexually active female participants of childbearing potential and sexually active male participants with female partners of childbearing potential must agree to use an acceptable method of contraception for the duration...
  • Stability on any current psychoactive medications (antidepressants, anti-anxiety medications, antipsychotics, stimulants, and mood stabilizers).
What rules you out
  • Untreated pneumothorax
  • History of spontaneous pneumothorax
  • Severe sinus infection
  • Upper respiratory infection
  • Asymptomatic pulmonary lesions on chest x-ray
  • Uncontrollable high fever (greater than 39C)
  • History of chest or ear surgery
  • Congenital spherocytosis
  • Any anemia or blood disorder
  • Any convulsive disorder
  • History of optic neuritis or sudden blindness
  • Middle ear infection
  • Diabetes mellitus (insulin therapy)
  • The subject is pregnant or lactating
  • Nicotine use/substance use/addiction
  • Acute Hypoglycemia
  • Diagnosed Chronic Obstructive Pulmonary Disease (COPD) and Emphysema
  • Presenting with symptoms of cough, congestion, vomiting, diarrhea, or open wounds.
  • Active malignancy
  • Current manic, delusional, or psychotic episodes
  • Serious/current suicidal ideations
  • Severe or unstable physical disorders or major cognitive deficits
  • Inability to attend scheduled clinic visits or comply with study protocols.
  • Treated with HBOT for any reason prior to study enrollment.
  • Non-English speakers
  • History of retinal repair, including laser photocoagulation or retinal detachment surgery.
  • History of middle ear surgery, including tympanoplasty, mastoidectomy, or pressure equalization tube placement.
  • Age greater than 75 years.
  • Use of any of the following medications during the study period: Anti-metabolites (e.g., methotrexate, azathioprine); Chemotherapuetic agents (e.g., cyclophosphamide, cisplatin); Mafenide acetate e.g., Sulfamylon)...

The study team makes the final eligibility decision.

Where it's taking place

  • Boise, Idaho, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Boise, Idaho, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.